Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis

Category	Detail
Condition
Key Mechanisms	Metabolic, microbial, and immune disturbances contributing to DIE risk, with emphasis on their interconnections.
Target Population
Care Setting

DIE is characterized by severe pelvic pain and infertility, highlighting the need for effective management.
Causal associations identified between metabolites, gut microbiota, and immune phenotypes with DIE susceptibility, underscoring the importance of multi-omics.
A five-gene panel was developed for potential diagnostic use in DIE, which may improve early detection.
Immunohistochemistry confirmed differential expression of key genes in DIE lesions, validating the multi-omics approach.
The study integrates multi-omics approaches to elucidate DIE pathophysiology, providing a comprehensive understanding.

Implement targeted therapies addressing metabolic and immune dysregulation, such as specific dietary interventions or immunomodulators.
Consider hormonal therapies and surgical options for symptom relief, including laparoscopic excision.

Focus on addressing metabolic and immune factors alongside traditional therapies, such as NSAIDs and hormonal treatments.

Incorporate genetic insights into clinical assessments of DIE, such as testing for specific genetic markers.
Utilize a multi-disciplinary approach for managing DIE, including gynecologists, pain specialists, and nutritionists.
Encourage patient education regarding the complex nature of DIE and its management, providing resources for support.

Clinical Scorecard: Integrative Multi-Omics Mendelian Randomization Reveals a Potential Gut-Immune-Pelvic Axis in Deep Infiltrating Endometriosis Through Metabolic, Microbial, and Immune Pathways